PRESS RELEASE
News
-
-
-
PRESS RELEASE
CCL Industries to Participate in Raymond James 45th Annual Institutional Investor Conference
CCL Industries Inc. executives to attend Raymond James 45th Annual Institutional Investor Conference on March 5, 2024, with CEO Geoffrey Martin participating in a webcast. Company overview and contact details available on www.cclind.com -
PRESS RELEASE
Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024
enVVeno Medical to present topline efficacy data from VenoValve U.S. pivotal trial at 2024 AVF Annual Meeting. VenoValve aims to address severe Chronic Venous Insufficiency with innovative bioprosthetic solutions -
PRESS RELEASE
EQS-Adhoc: Cliq Digital AG: CLIQ Digital resolves to return capital to shareholders by means of a share buyback programme of up to €13 million and not through the distribution of a dividend in 2024
CLIQ Digital AG initiates a share buyback programme of up to €13 million instead of distributing a dividend in 2024, aiming to enhance shareholder value and share price stability -
PRESS RELEASE
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG releases notification of major holdings according to Article 40, Section 1 of the German Securities Trading Act. The Goldman Sachs Group, Inc. acquires voting rights in TUI AG -
-
PRESS RELEASE
Tharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic Candidate
Tharimmune, Inc. announces successful Phase 1 trial completion for TH104, a promising treatment for chronic pruritus in primary biliary cholangitis. The study shows positive safety and tolerability profile aligned with previous findings -
PRESS RELEASE
Air Techniques Announces the Newest All-Star at the Chicago Midwinter Meeting – Popcorn Included
Air Techniques, Inc. to showcase innovative FlowStar Nitrous Flowmeters and Components at the Chicago Midwinter Meeting. Attendees can see the latest nitrous oxide/oxygen sedation products and demo VisionX Imaging Software for free Garrett Popcorn -
